Page last updated: 2024-08-17

carbostyril and Elevated ICP (Intracranial Pressure)

carbostyril has been researched along with Elevated ICP (Intracranial Pressure) in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Aylward, SC; Jordan, CO; Kopp, BT; Paul, GR; Wisniewski, BL1
Aujard, Y; Bedu, A; Brisse, H; Farnoux, C; Le Huidoux, P; Naar, I1

Other Studies

2 other study(ies) available for carbostyril and Elevated ICP (Intracranial Pressure)

ArticleYear
Hypervitaminosis A with fulminant secondary intracranial hypertension following personalized medicine-based Elexacaftor/Tezacaftor/Ivacaftor initiation in a preadolescent with cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2022, Volume: 21, Issue:3

    Topics: Aminophenols; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Humans; Hypervitaminosis A; Indoles; Intracranial Hypertension; Precision Medicine; Pyrazoles; Pyridines; Pyrrolidines; Quinolones

2022
[Intracranial hypertension in a newborn treated with quinolone].
    Presse medicale (Paris, France : 1983), 1998, Jun-27, Volume: 27, Issue:23

    Topics: 4-Quinolones; Adult; Anti-Infective Agents; Bacteremia; Ceftazidime; Child; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Infant, Newborn; Infant, Premature; Intracranial Hypertension; Male; Parenteral Nutrition; Pefloxacin; Quinolones; Remission, Spontaneous

1998